封面
市场调查报告书
商品编码
1426493

2024 年脊椎治疗全球市场报告

Kyphoscoliosis Treatment Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

脊椎治疗的市场规模预计在未来几年将显着成长。预计到 2028 年将以 5.7% 的复合年增长率 (CAGR) 增长至 38.4 亿美元。预测期内的预期增长可归因于个人化治疗方法、动态研究的扩展、远端监控和远端医疗服务的使用增加以及正在进行的基因研究。预测期内预计的主要趋势包括采用先进的手术技术、创新的矫正器具技术、制定客製化的治疗计划、增加医疗领域3D列印的采用以及疼痛管理的持续成长,包括创新。

脊髓损伤的预期增加将推动脊椎后凸治疗市场的成长。脊髓损伤包括各种脊椎结构的创伤和损伤,导致脊椎等病症并影响脊椎的排列。治疗与脊髓损伤相关的脊椎后凸需要综合方法,包括整形外科评估、物理治疗、矫正器具、潜在手术、疼痛管理和多学科医疗团队。值得注意的是,根据纽西兰脊髓信託基金会报告,运动和休閒造成的脊髓损伤呈上升趋势,从 2020 年的 14% 增加到 2021 年的 19%。这种上升趋势受到山地自行车和自行车等活动的影响,凸显了脊椎后凸治疗市场中脊椎损伤数量不断增加的驱动力。

远端医疗的日益普及预计将成为脊椎治疗市场成长的关键驱动力。远端医疗利用电讯技术提供远距医疗服务,促进与骨科医生和脊椎外科医生的远距会诊。这对于因脊椎后凸相关的身体限製而难以前往医疗机构的个人尤其有益。根据美国疾病管制与预防中心 (CDC) 的数据,到 2021 年,37% 的人(包括 42% 的女性)将继续使用远端医疗,这使得远端医疗的普及更加广泛且普及治疗脊椎后侧凸。推动市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章市场区隔

  • 全球脊椎治疗市场,按类型细分、实际和预测,2018-2023、2023-2028、2033
  • 姿势性后凸
  • 谢尔曼脊柱后凸
  • 先天性脊柱后凸
  • 全球脊椎治疗市场,依治疗、表现及预测细分,2018-2023、2023-2028、2033
  • 药品
  • 手术和固定装置
  • 全球脊椎治疗市场,按最终用户细分,实际和预测,2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 门诊手术中心

第 7 章 区域与国家分析

  • 全球脊椎治疗市场,按地区、实际和预测,2018-2023、2023-2028、2033
  • 全球脊椎治疗市场,依国家、实际及预测,2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 脊椎治疗市场的竞争形势
  • 脊椎治疗市场公司概况
    • Johnson &Johnson Services Inc.
    • Aspen Medical Products LLC
    • Medtronic plc
    • Stryker Corporation
    • Milwaukee Brace Company

第31章 其他大型创新公司

  • Zimmer Biomet Holdings Inc.
  • Perrigo Company plc
  • Teva Pharmaceuticals Inc.
  • B. Braun Melsungen Aktiengesellschaft
  • Aurobindo Pharma Limited
  • Integra LifeSciences Ltd.
  • NuVasive Inc.
  • DJO Global Inc.
  • Globus Medical Inc.
  • Boston Orthotics &Prosthetics
  • Ossur hf.
  • Aesculap Inc.
  • DeRoyal Industries Inc.
  • MicroPort Scientific Corp.
  • Alphatec Holdings Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13505

Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies aimed at managing and correcting the spinal deformity, improving posture, reducing pain, and preventing further spinal curvature.

The main types of kyphoscoliosis include postural kyphosis, Scheuermann's kyphosis, congenital kyphosis, and kyphoscoliosis. Postural kyphosis refers to the rounding or hunching of the back, typically affecting teenagers and young adults. Treatment options for kyphoscoliosis encompass medications, surgery, and bracing, and these are implemented by hospitals, clinics, and ambulatory surgical centers.

The kyphoscoliosis treatment market research report is one of a series of new reports from The Business Research Company that provides kyphoscoliosis treatment market statistics, including kyphoscoliosis treatment industry global market size, regional shares, competitors with a kyphoscoliosis treatment market share, detailed kyphoscoliosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the kyphoscoliosis treatment industry. This kyphoscoliosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $2.89 billion in 2023 to $3.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The increase observed in the historical period can be attributed to the exploration of regenerative medicine, contributions from genetic research, the adoption of telemedicine and remote monitoring, and advancements in rehabilitation programs.

The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The anticipated growth in the forecast period can be attributed to personalized treatment approaches, the expansion of biomechanical research, the increased utilization of remote monitoring and telehealth services, and ongoing genetic research. Major trends expected in the forecast period involve advanced surgical techniques, the adoption of innovative bracing technologies, the development of customized treatment plans, the increased adoption of 3D printing in the medical field, and ongoing innovations in pain management.

The anticipated increase in spinal cord injuries is poised to drive the growth of the kyphoscoliosis treatment market. Spinal cord injuries encompass trauma or damage to various spine structures, leading to conditions such as kyphoscoliosis and impacting spinal alignment. Treatment for kyphoscoliosis linked with spinal cord injuries involves a comprehensive approach, including orthopedic evaluation, physical therapy, bracing, potential surgery, pain management, and a multidisciplinary healthcare team. Notably, there has been a rise in sporting and recreational spinal cord injuries, increasing from 14% in 2020 to 19% in 2021, as reported by the New Zealand Spinal Trust. This upward trend, influenced by activities such as mountain biking and cycling, underscores the driving force of the rising number of spinal cord injuries on the kyphoscoliosis treatment market.

The escalating use of telemedicine is expected to be a significant driver of growth in the kyphoscoliosis treatment market. Telemedicine, utilizing telecommunications technology for remote clinical services, facilitates remote consultations with orthopedic specialists and spine surgeons. This is particularly beneficial for individuals facing difficulties in traveling to healthcare facilities due to the physical limitations associated with kyphoscoliosis. The widespread utilization of telehealth, with 37% of individuals, including 42% of women, continuing to use it in 2021 according to the Centers for Disease Control and Prevention (CDC), is a key factor propelling the growth of the kyphoscoliosis treatment market.

The increasing incidence of genetic disorders is expected to be a significant catalyst for the growth of the kyphoscoliosis treatment market. Genetic disorders, stemming from abnormalities or mutations in an individual's DNA, often involve spinal curvature abnormalities requiring kyphoscoliosis treatment. The prevalence of genetic conditions in children is estimated to be 1 in 25 in the UK, affecting over 2.4 million individuals. The multidisciplinary treatment approach, encompassing various strategies such as beta-blocker therapy, physical therapy, and orthopedic surgeon supervision, underlines the pivotal role of kyphoscoliosis treatment in managing genetic disorders and contributes to market growth.

The high cost of treatment poses a challenge and may impede the market's growth during the forecast period. Surgical interventions, characterized by complexity and the need for specialized equipment and expertise, incur substantial costs. This financial burden can be particularly prohibitive in underdeveloped nations with limited healthcare resources. For instance, the average cost of revision surgery due to proximal junctional kyphosis (PJK) in adult spinal deformity patients was $93,688, significantly higher than $21,467. The high cost of treatment acts as a hindrance to the growth of the kyphoscoliosis treatment market.

Major companies in the kyphoscoliosis treatment market are focusing on innovative product development, exemplified by the MARVEL Growing Rod System designed for early-onset scoliosis. The MARVEL Growing Rod System, launched by Globus Medical Inc., is a posterior stabilizing rod that can be surgically implanted and periodically stretched, offering substantial diversion, immediate tactile feedback, and automated locking for dependable growth. This innovation, including cutting-edge items such as the Growing Rod System, is anticipated to contribute to the future expansion of the market.

Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic plc, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company plc, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

North America was the largest region in the kyphoscoliosis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the kyphoscoliosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The kyphoscoliosis treatment market consists of revenues earned by entities by providing services such as physical therapy, pain management, specialist psychological support, and medical evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kyphoscoliosis treatment market also includes sales of lumbar support cushions, orthopedic braces, back support belts, and exercise and therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kyphoscoliosis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kyphoscoliosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kyphoscoliosis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kyphoscoliosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Postural Kyphosis; Scheuermann's Kyphosis; Congenital Kyphosis
  • 2) By Treatment: Medications; Surgery And Bracing
  • 3) By End-User: Hospital; Clinics; Ambulatory Surgical Centers
  • Companies Mentioned: Johnson & Johnson Services Inc.; Aspen Medical Products LLC; Medtronic plc; Stryker Corporation; Milwaukee Brace Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Kyphoscoliosis Treatment Market Characteristics

3. Kyphoscoliosis Treatment Market Trends And Strategies

4. Kyphoscoliosis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Kyphoscoliosis Treatment Market Size and Growth

  • 5.1. Global Kyphoscoliosis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Kyphoscoliosis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Kyphoscoliosis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Kyphoscoliosis Treatment Market Segmentation

  • 6.1. Global Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Postural Kyphosis
  • Scheuermann's Kyphosis
  • Congenital Kyphosis
  • 6.2. Global Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medications
  • Surgery And Bracing
  • 6.3. Global Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers

7. Kyphoscoliosis Treatment Market Regional And Country Analysis

  • 7.1. Global Kyphoscoliosis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Kyphoscoliosis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Kyphoscoliosis Treatment Market

  • 8.1. Asia-Pacific Kyphoscoliosis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Kyphoscoliosis Treatment Market

  • 9.1. China Kyphoscoliosis Treatment Market Overview
  • 9.2. China Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Kyphoscoliosis Treatment Market

  • 10.1. India Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Kyphoscoliosis Treatment Market

  • 11.1. Japan Kyphoscoliosis Treatment Market Overview
  • 11.2. Japan Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Kyphoscoliosis Treatment Market

  • 12.1. Australia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Kyphoscoliosis Treatment Market

  • 13.1. Indonesia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Kyphoscoliosis Treatment Market

  • 14.1. South Korea Kyphoscoliosis Treatment Market Overview
  • 14.2. South Korea Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Kyphoscoliosis Treatment Market

  • 15.1. Western Europe Kyphoscoliosis Treatment Market Overview
  • 15.2. Western Europe Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Kyphoscoliosis Treatment Market

  • 16.1. UK Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Kyphoscoliosis Treatment Market

  • 17.1. Germany Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Kyphoscoliosis Treatment Market

  • 18.5. France Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Kyphoscoliosis Treatment Market

  • 19.9. Italy Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Kyphoscoliosis Treatment Market

  • 20.13. Spain Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Kyphoscoliosis Treatment Market

  • 21.1. Eastern Europe Kyphoscoliosis Treatment Market Overview
  • 21.2. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Kyphoscoliosis Treatment Market

  • 22.1. Russia Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Kyphoscoliosis Treatment Market

  • 23.1. North America Kyphoscoliosis Treatment Market Overview
  • 23.2. North America Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Kyphoscoliosis Treatment Market

  • 24.1. USA Kyphoscoliosis Treatment Market Overview
  • 24.2. USA Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Kyphoscoliosis Treatment Market

  • 25.1. Canada Kyphoscoliosis Treatment Market Overview
  • 25.2. Canada Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Kyphoscoliosis Treatment Market

  • 26.1. South America Kyphoscoliosis Treatment Market Overview
  • 26.2. South America Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Kyphoscoliosis Treatment Market

  • 27.1. Brazil Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Kyphoscoliosis Treatment Market

  • 28.1. Middle East Kyphoscoliosis Treatment Market Overview
  • 28.2. Middle East Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Kyphoscoliosis Treatment Market

  • 29.1. Africa Kyphoscoliosis Treatment Market Overview
  • 29.2. Africa Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Kyphoscoliosis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Kyphoscoliosis Treatment Market Competitive Landscape
  • 30.2. Kyphoscoliosis Treatment Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Aspen Medical Products LLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Stryker Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Milwaukee Brace Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Kyphoscoliosis Treatment Market Other Major And Innovative Companies

  • 31.1. Zimmer Biomet Holdings Inc.
  • 31.2. Perrigo Company plc
  • 31.3. Teva Pharmaceuticals Inc.
  • 31.4. B. Braun Melsungen Aktiengesellschaft
  • 31.5. Aurobindo Pharma Limited
  • 31.6. Integra LifeSciences Ltd.
  • 31.7. NuVasive Inc.
  • 31.8. DJO Global Inc.
  • 31.9. Globus Medical Inc.
  • 31.10. Boston Orthotics & Prosthetics
  • 31.11. Ossur hf.
  • 31.12. Aesculap Inc.
  • 31.13. DeRoyal Industries Inc.
  • 31.14. MicroPort Scientific Corp.
  • 31.15. Alphatec Holdings Inc.

32. Global Kyphoscoliosis Treatment Market Competitive Benchmarking

33. Global Kyphoscoliosis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Kyphoscoliosis Treatment Market

35. Kyphoscoliosis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Kyphoscoliosis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Kyphoscoliosis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Kyphoscoliosis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer